Scolaris Content Display Scolaris Content Display

Comparison 1 Discontinued versus continued, Outcome 1 Instrumental delivery.
Figures and Tables -
Analysis 1.1

Comparison 1 Discontinued versus continued, Outcome 1 Instrumental delivery.

Comparison 1 Discontinued versus continued, Outcome 2 Instrumental delivery by subgroup analysis.
Figures and Tables -
Analysis 1.2

Comparison 1 Discontinued versus continued, Outcome 2 Instrumental delivery by subgroup analysis.

Comparison 1 Discontinued versus continued, Outcome 3 Caesarean section.
Figures and Tables -
Analysis 1.3

Comparison 1 Discontinued versus continued, Outcome 3 Caesarean section.

Comparison 1 Discontinued versus continued, Outcome 4 Caesarean section by subgroup analysis.
Figures and Tables -
Analysis 1.4

Comparison 1 Discontinued versus continued, Outcome 4 Caesarean section by subgroup analysis.

Comparison 1 Discontinued versus continued, Outcome 5 Spontaneous vaginal delivery.
Figures and Tables -
Analysis 1.5

Comparison 1 Discontinued versus continued, Outcome 5 Spontaneous vaginal delivery.

Comparison 1 Discontinued versus continued, Outcome 6 Spontaneous vaginal delivery by subgroup analysis.
Figures and Tables -
Analysis 1.6

Comparison 1 Discontinued versus continued, Outcome 6 Spontaneous vaginal delivery by subgroup analysis.

Comparison 1 Discontinued versus continued, Outcome 7 Duration of 2nd stage.
Figures and Tables -
Analysis 1.7

Comparison 1 Discontinued versus continued, Outcome 7 Duration of 2nd stage.

Comparison 1 Discontinued versus continued, Outcome 8 Duration of 2nd stage by subgroup analysis.
Figures and Tables -
Analysis 1.8

Comparison 1 Discontinued versus continued, Outcome 8 Duration of 2nd stage by subgroup analysis.

Comparison 1 Discontinued versus continued, Outcome 9 Fetal malposition.
Figures and Tables -
Analysis 1.9

Comparison 1 Discontinued versus continued, Outcome 9 Fetal malposition.

Comparison 1 Discontinued versus continued, Outcome 10 Fetal malposition by subgroup analysis.
Figures and Tables -
Analysis 1.10

Comparison 1 Discontinued versus continued, Outcome 10 Fetal malposition by subgroup analysis.

Comparison 1 Discontinued versus continued, Outcome 11 Inadequate pain relief.
Figures and Tables -
Analysis 1.11

Comparison 1 Discontinued versus continued, Outcome 11 Inadequate pain relief.

Comparison 1 Discontinued versus continued, Outcome 12 Inadequate pain relief by subgroup analysis.
Figures and Tables -
Analysis 1.12

Comparison 1 Discontinued versus continued, Outcome 12 Inadequate pain relief by subgroup analysis.

Comparison 1 Discontinued versus continued, Outcome 13 Apgar score < 7 or < 8 at 1 minute.
Figures and Tables -
Analysis 1.13

Comparison 1 Discontinued versus continued, Outcome 13 Apgar score < 7 or < 8 at 1 minute.

Comparison 1 Discontinued versus continued, Outcome 14 Apgar score < 7 or < 8 at 1 minute by subgroup analysis.
Figures and Tables -
Analysis 1.14

Comparison 1 Discontinued versus continued, Outcome 14 Apgar score < 7 or < 8 at 1 minute by subgroup analysis.

Comparison 1 Discontinued versus continued, Outcome 15 Apgar score < 7 at 5 minutes.
Figures and Tables -
Analysis 1.15

Comparison 1 Discontinued versus continued, Outcome 15 Apgar score < 7 at 5 minutes.

Comparison 1 Discontinued versus continued, Outcome 16 Umbilical arterial pH.
Figures and Tables -
Analysis 1.16

Comparison 1 Discontinued versus continued, Outcome 16 Umbilical arterial pH.

Comparison 1 Discontinued versus continued, Outcome 17 Umbilical arterial pH by subgroup analysis.
Figures and Tables -
Analysis 1.17

Comparison 1 Discontinued versus continued, Outcome 17 Umbilical arterial pH by subgroup analysis.

Comparison 1. Discontinued versus continued

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Instrumental delivery Show forest plot

5

462

Risk Ratio (M‐H, Fixed, 95% CI)

0.84 [0.61, 1.15]

2 Instrumental delivery by subgroup analysis Show forest plot

5

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

2.1 Continuous infusion

4

388

Risk Ratio (M‐H, Fixed, 95% CI)

0.81 [0.58, 1.12]

2.2 Intermittant bolus

1

74

Risk Ratio (M‐H, Fixed, 95% CI)

1.2 [0.40, 3.59]

2.3 LA alone

4

399

Risk Ratio (M‐H, Fixed, 95% CI)

0.85 [0.62, 1.18]

2.4 LA + opioid

1

63

Risk Ratio (M‐H, Fixed, 95% CI)

0.71 [0.24, 2.09]

3 Caesarean section Show forest plot

4

282

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.43, 2.25]

4 Caesarean section by subgroup analysis Show forest plot

4

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

4.1 Continuous infusion

3

208

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.39, 2.46]

4.2 Intermittant bolus

1

74

Risk Ratio (M‐H, Fixed, 95% CI)

1.0 [0.15, 6.73]

4.3 LA alone

3

219

Risk Ratio (M‐H, Fixed, 95% CI)

1.11 [0.46, 2.68]

4.4 LA + opioid

1

63

Risk Ratio (M‐H, Fixed, 95% CI)

0.29 [0.01, 6.76]

5 Spontaneous vaginal delivery Show forest plot

4

282

Risk Ratio (M‐H, Fixed, 95% CI)

1.11 [0.95, 1.30]

6 Spontaneous vaginal delivery by subgroup analysis Show forest plot

4

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

6.1 Continuous infusion

3

208

Risk Ratio (M‐H, Fixed, 95% CI)

1.18 [0.97, 1.45]

6.2 intermittant bolus

1

74

Risk Ratio (M‐H, Fixed, 95% CI)

0.97 [0.77, 1.22]

6.3 LA alone

3

219

Risk Ratio (M‐H, Fixed, 95% CI)

1.11 [0.92, 1.34]

6.4 LA + opioid

1

63

Risk Ratio (M‐H, Fixed, 95% CI)

1.12 [0.88, 1.44]

7 Duration of 2nd stage Show forest plot

3

203

Mean Difference (IV, Fixed, 95% CI)

‐5.80 [‐12.91, 1.30]

8 Duration of 2nd stage by subgroup analysis Show forest plot

3

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

8.1 Continuous infusion

2

133

Mean Difference (IV, Fixed, 95% CI)

‐15.12 [‐35.42, 5.18]

8.2 Intermittant bolus

1

70

Mean Difference (IV, Fixed, 95% CI)

‐4.5 [‐12.09, 3.09]

9 Fetal malposition Show forest plot

4

388

Risk Ratio (M‐H, Fixed, 95% CI)

1.36 [0.73, 2.56]

10 Fetal malposition by subgroup analysis Show forest plot

4

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

10.3 LA alone

3

325

Risk Ratio (M‐H, Fixed, 95% CI)

1.38 [0.70, 2.71]

10.4 LA + opioid

1

63

Risk Ratio (M‐H, Fixed, 95% CI)

1.28 [0.23, 7.14]

11 Inadequate pain relief Show forest plot

4

384

Risk Ratio (M‐H, Fixed, 95% CI)

3.68 [1.99, 6.80]

12 Inadequate pain relief by subgroup analysis Show forest plot

4

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

12.3 LA alone

3

321

Risk Ratio (M‐H, Fixed, 95% CI)

3.44 [1.81, 6.53]

12.4 LA + opioid

1

63

Risk Ratio (M‐H, Fixed, 95% CI)

5.97 [0.78, 45.73]

13 Apgar score < 7 or < 8 at 1 minute Show forest plot

4

388

Risk Ratio (M‐H, Fixed, 95% CI)

1.55 [0.94, 2.55]

14 Apgar score < 7 or < 8 at 1 minute by subgroup analysis Show forest plot

4

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

14.3 LA alone

3

325

Risk Ratio (M‐H, Fixed, 95% CI)

1.77 [1.03, 3.03]

14.4 LA + opioid

1

63

Risk Ratio (M‐H, Fixed, 95% CI)

0.64 [0.16, 2.63]

15 Apgar score < 7 at 5 minutes Show forest plot

3

208

Risk Ratio (M‐H, Fixed, 95% CI)

3.92 [0.45, 34.21]

16 Umbilical arterial pH Show forest plot

3

208

Mean Difference (IV, Fixed, 95% CI)

‐0.01 [‐0.03, 0.01]

17 Umbilical arterial pH by subgroup analysis Show forest plot

3

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

17.3 LA alone

2

145

Mean Difference (IV, Fixed, 95% CI)

‐0.02 [‐0.05, 0.00]

17.4 LA + opioid

1

63

Mean Difference (IV, Fixed, 95% CI)

0.01 [‐0.02, 0.04]

Figures and Tables -
Comparison 1. Discontinued versus continued